Goetz MP, Okera M, Wildiers H, Campone M, et al. Safety and efficacy of abemaciclib plus endocrine therapy in older patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: an age-specific subgroup analysis of MONARCH 2 and 3 trials. Breast Cancer Res Treat 2021 Jan 3. pii: 10.1007/s10549-020-06029.
PMID: 33392835